Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Yasmin Settlements Climb to $142 Million

(EMAILWIRE.COM, May 18, 2012 ) New York, NY – Yasmin settlements have climbed to $142 million, averaging $218,000 per case, according to a number of news sources. Bayer has reportedly resolved 651 lawsuits alleging that its Yasmin and Yaz birth control pills caused sometimes-fatal blood clots in women, with one financial analyst reportedly estimating that Bayer may have to pay out more than $2.65 billion to resolve all cases surrounding these oral contraceptives. If you or a loved one suffered a blood clot while taking Yaz or Yasmin, you may still be able to file a claim against the manufacturer to seek compensation for medical expenses and other losses. To learn more about the Yasmin settlements and to have your claim evaluated at no cost to you, please visit http://www.classaction.org/yaz-yasmin.html today.

The news of the Yasmin settlements came shortly after the FDA ordered a stronger blood clot warning on Yaz and Yasmin labels. The new labels will include information that some studies have found up to a threefold increase in the risk of blood clots with pills containing drospirenone, a hormone found in Yaz, Yasmin and other newer, fourth-generation birth control pills. The agency’s own study found that 10 in 10,000 women taking oral contraceptives containing this synthetic hormone would get a blood clot per year, compared to approximately six in 10,000 women using older birth control pills. This announcement of the label update was made after an advisory committee of outside experts to the agency voted for pills containing drospirenone to undergo a label revision to more clearly outline their risks and benefits.

Reportedly, Bayer is facing 11,900 lawsuits over its Yaz and Yasmin oral contraceptives. Bayer has agreed to settle the first group of lawsuits for venous clot injuries – deep vein thrombosis (DVT) or pulmonary embolism (PE) - while other suits are still in progress. If you suffered a venous clot injury while taking Yaz or Yasmin, it’s not too late to make a claim. For a free evaluation of your blood clot claim, visit ClassAction.org today.

About Class Action.org

Class Action.org is dedicated to protecting consumers and investors in class actions and complex litigation throughout the United States. Class Action.org keeps consumers informed about product alerts, recalls, and emerging litigation and helps them take action against the manufacturers of defective products, drugs, and medical devices. Information about consumer fraud issues and environmental hazards is also available on the site. Visit http://www.classaction.org today for a no cost, no obligation case evaluation and information about your consumer rights.

ClassAction.org
Hannah Armstrong
800-449-1970
pressrelease@lawyercentral.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Exclusive: Pay per puff? Caffeine stick? E-cigarette boom sparks race for new...
24 Nov 2014 at 12:09pm

By Martinne Geller and Ben Hirschler LONDON (Reuters) - Electronic cigarette makers are racing to design and buy variations of a technology that has lit a billion-dollar boom, created a new vocabulary, and prompted a backlash from health officials worried about the impact of the new smokeless devices. ...


College student in custody after Texas military post lockdown
24 Nov 2014 at 11:49am
By Jim Forsyth SAN ANTONIO (Reuters) - A male college student has been taken into custody for driving an unauthorized vehicle onto San Antonio's Fort Sam Houston on Sunday night, sparking a lockdown and a full security alert, officials said on Monday. The San Antonio area man, who has not been identified, was alone in his car when military police pulled him over after a brief pursuit. He had no weapons or explosives in his vehicle, said Joint Base San Antonio spokesman Alex Delgado. ...


U.N. to miss Dec 1 Ebola target due to rising Sierra Leone cases
24 Nov 2014 at 11:21am

By Matthew Mpoke Bigg ACCRA (Reuters) - The U.N. Ebola Emergency Response Mission will not fully meet its Dec. 1 target for containing the virus due to escalating numbers of cases in Sierra Leone, Anthony Banbury, the head of UNMEER, said on Monday. The mission set the goal in September of having 70 percent of Ebola patients under treatment and 70 percent of victims safely buried. That target will be achieved in some areas, Banbury told Reuters, citing progress in Liberia. "We are going to exceed the Dec 1 targets in some areas. But we are almost certainly going to fall short in others. ...


Little understood chemicals cut men?s fertility
24 Nov 2014 at 11:17am
By Ronnie Cohen (Reuters Health) ? A new study suggests that chemicals in sunscreen may impair men?s ability to father children, government scientists say. But other experts question whether the chemicals wound up in men?s urine from sunscreen or through another route. The FDA has not authorized the substances ? benzophenone-2, known as BP-2, and 4-hydroxybenzophenone, known as 4-OH-BP ? for use in sunscreens. BP-2 does show up as an ingredient in aftershaves, colognes, antiperspirant and other personal-care products. ...

HealthSouth buys home health operator as U.S. population ages
24 Nov 2014 at 11:05am
(Reuters) - Hospital operator HealthSouth Corp bought the owner of Encompass Home Health and Hospice, the latest deal in an industry that looks poised to grow as the U.S. population ages. HealthSouth, whose shares were up 3.8 percent at $39.72 in afternoon trading on Monday, said it was looking for further acquisitions in the fragmented sector. The company bought Encompass' owner, EHHI Holdings Inc, for about $750 million from healthcare-focused private investment firm Cressey & Co LP, expanding its home health business by adding 140 locations across 13 U.S. states. ...


'Dramatic improvement' in Ebola outlook in Liberia: U.S. general
24 Nov 2014 at 10:22am

By Emma Farge DAKAR (Reuters) - A U.S. general in the force helping Liberia fight the Ebola epidemic reported on Monday a dramatic improvement in the situation there and confirmed the cancellation of two planned treatment facilities. Brigadier General Frank Tate, deputy commanding general of U.S. Operation United Assistance, said the drop in the number of cases in the country was all the more encouraging given recent improvements in reporting capacity. He said new daily cases have fallen to around 20 from close to 80 when the operation was announced in September. ...



How My Mother's Death Gave Me a New Attitude
24 Nov 2014 at 9:38am

I never knew that at age 26, I would become a motherless daughter. Lost. Confused. Indecisive. Stressed. Clueless. I've been reading countless books, articles, guides searching for advice from other women who share their stories of survival, confusion, uncertainty, hope and prosperity. Their stories show similarity with my situation but none...



U.S. seeks to step up India trade talks after WTO breakthrough
24 Nov 2014 at 9:25am

NEW DELHI (Reuters) - The United States wants to step up its trade dialogue with India, Trade Representative Michael Froman said on Monday, after the resolution of a global trade dispute paved the way for President Barack Obama to visit India. Direct contacts between Obama and Prime Minister Narendra Modi this month helped to end a deadlock that had prevented the World Trade Organization from implementing a $1 trillion package of reforms to global customs rules. ...



BioMarin to buy Prosensa in $840 million deal
24 Nov 2014 at 9:24am

(Reuters) - BioMarin Pharmaceuticals Inc said it would buy Dutch drug developer Prosensa Holding NV for about $840 million including milestone payments, aiming to add to its portfolio of drugs to treat rare diseases.



Confession of accused Etan Patz killer admissible as evidence: NY court
24 Nov 2014 at 9:24am

By Natasja Sheriff NEW YORK (Reuters) - The confession of a man accused of killing 6-year-old Etan Patz, who vanished from a New York street more than three decades ago, can be used as evidence against him, a Manhattan court ruled on Monday. Pedro Hernandez, who confessed to police in 2012 that he had choked Patz and stuffed him alive in a garbage bag in 1979, has been charged with murder. Hernandez, a New Jersey man who at the time of the boy's disappearance worked at a deli in his Soho neighborhood, no longer admits to the crime, according to his lawyer, Harvey Fishbein. ...


United Nations members resolve to end child marriage
24 Nov 2014 at 9:18am
By Mirjam Donath UNITED NATIONS (Reuters) - The United Nations agreed on Friday that all members should pass and enforce laws banning child marriages, resolving to end a practice that affects about 15 million girls every year. The committee of the 193-nation General Assembly that deals with human rights adopted by consensus a resolution urging all states to take steps to end "child, early and forced marriage." There are now more than 700 million women who were married before their 18th birthday, many in conditions of poverty and insecurity, according to U.N. statistics. ...

The Skinny on Nestle's New Exercise in a Bottle Project
24 Nov 2014 at 8:50am
Exercise in a bottle? Maybe someday.

Merck buys rights to NewLink's experimental Ebola vaccine
24 Nov 2014 at 8:47am
By Ransdell Pierson (Reuters) - Merck & Co Inc on Monday said it would buy worldwide commercial rights to NewLink Genetics Corp's experimental vaccine against the Ebola virus. NewLink, whose subsidiary licensed commercial rights to the rVSV-EBOV vaccine in 2010, said it would receive $50 million plus royalties from Merck. Large late-stage trials of the product could begin early next year, said Merck, the No. 2 U.S. drugmaker and one of the world's biggest makers of vaccines. ...

FDA tightens guidelines on technique for uterine fibroid surgery
24 Nov 2014 at 8:12am
By Toni Clarke WASHINGTON (Reuters) - The U.S. Food and Drug Administration has tightened its guidelines on the use of a uterine surgical technique, saying it has been linked to the spread of a rare type of cancer. The agency said on Monday it is recommending that a boxed warning be placed on laparoscopic power morcellator devices used to treat uterine fibroids. Such an FDA warning is the strongest that a medication or treatment can carry while still remaining on the U.S. market. ...

Boutique fitness studios harden bodies with personalized approach
24 Nov 2014 at 7:27am
By Dorene Internicola NEW YORK (Reuters) - Boutique studios that offer a more personal approach to fitness and a softer ambience than big box gyms are a growing part of the $22.4 billion U.S. industry. IHRSA, the International Health, Racquet & Sportsclub Association that is the trade association of the fitness industry, noted in its 2014 Health Club Consumer Report that personalized fitness studios, or boutiques, captured 21 percent of the market in 2013, which rose from $21.8 billion in 2012. ...

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC